AbbVie Inc (ABBV) Stock Price Today
Aura AI Summary
Key Stats
- $439.62BMarket Cap
- -Volume
- HealthSector
- $265.9752W High
- $197.3852W Low
- -Typical Hold Time
- $503.88BEnterprise Value
- 2.78%Div Yield
- -Trading Activity
Track AbbVie Inc (ABBV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, AbbVie Inc has traded between a low of $197.38 and a high of $265.97, highlighting its annual price range. Buy and sell AbbVie Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Most Recent News
Norwegian Cruise shares drop 3% as rising oil prices hurt fuel-cost outlook
Shares of Norwegian Cruise Line fell 3% due to rising oil prices, which increase fuel costs and pressure profit margins. Carnival and Royal Caribbean stocks also declined but less sharply, as Norwegian's higher debt and smaller scale make it more vul...

GE Aerospace's $12B acquisition of Consolidated Precision Products boosts defense supply chain and stock outlook.
GE Aerospace is acquiring Consolidated Precision Products for nearly $12 billion to bring its jet engine castings supply in-house, addressing a key manufacturing bottleneck. This move strengthens GE's defense segment, which showed strong revenue grow...

UiPath shares drop 3% despite Citi's Buy rating and $23 target amid mixed investor sentiment.
UiPath shares fell 3% to $13.55 even after Citi initiated coverage with a Buy rating and a $23 price target, citing UiPath's role in AI orchestration. The decline follows a third-quarter revenue guide below expectations, causing investor caution desp...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.